Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies.

52W Range

32ndpctl

Volume

0.03×avg

Market Cap

22.00MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

NextCure, Inc.

NXTCNASDAQ Global Select·USD·Closed

NextCure, Inc.

NXTCNASDAQ·USD·Closed

$6.09

+0.91%

$6.09

+$0.05 (0.91%)

52W Range

32ndpctl

Volume

0.03×avg

Mkt Cap

22.00MUSD

P/E

-0.6TTM

Div Yield

–ann

NXTC: NextCure, Inc. Stock Analysis | finqOS